Feeds:
Posts
Comments

Archive for the ‘Neurobiological Technologies Inc (NASDAQ:NTII)’ Category

Greenbackd Portfolio Q2 Performance and Update

Posted in About, Autobytel (NASDAQ:ABTL), Avigen (NASDAQ:AVGN), Axcelis Technologies Inc (NASDAQ:ACLS), Ditech Networks Inc (NASDAQ:DITC), Greenbackd, Greenbackd Portfolio, Liquidation Value, MathStar Inc (OTC:MATH), Network Engines Inc (NASDAQ:NENG), Neurobiological Technologies Inc (NASDAQ:NTII), Northstar Neuroscience Inc (NASDAQ:NSTR), Rackable Systems Inc (NASDAQ:RACK), Soapstone Networks Inc (NASDAQ:SOAP), Stocks, Vanda Pharmaceuticals Inc (NASDAQ:VNDA), VaxGen Inc (OTC:VXGN), tagged , , , , , , , on June 1, 2009 | Leave a Comment »

Update June 16, 2009: SOAP has announced that it proposes to liquidate. See our post below. Update June 3, 2009: We’ve pinned this post to the front page. Any new posts between now and July 4th will appear below this post. — June 1, 2009 marked the end of Greenbackd’s second quarter. It’s time again [...]

Read Full Post »

Neurobiological Technologies Inc (NASDAQ:NTII) 10Q update; Greenbackd exits

Posted in Activist Investors, Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ:NTII), Stocks, tagged , , , , , on May 11, 2009 | 2 Comments »

Neurobiological Technologies Inc (NASDAQ:NTII) has filed its 10Q for the period ended march 31, 2009. After reviewing the 10Q, we have reduced our estimate of NTII’s liquidation value to $19.6M or $0.73 per share. NTII closed on Friday at $0.72, which is approximately our estimate of its value, and so we are taking the opportunity [...]

Read Full Post »

NTII on the block; engages financial adviser

Posted in Activist Investors, Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ:NTII), Stocks, tagged , , , on March 31, 2009 | Leave a Comment »

Neurobiological Technologies Inc (NASDAQ:NTII) has engaged a financial adviser to explore a sale of the company or its major assets to determine “if there is a transaction more beneficial to our shareholders than a liquidation,” according to its CEO, William Fletcher. We’ve been following NTII (see our post archive here) because it’s trading at a [...]

Read Full Post »

NYTimes says investors want biotech firms to cash out

Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, Neurobiological Technologies Inc (NASDAQ:NTII), Northstar Neuroscience Inc (NASDAQ:NSTR), Stocks, tagged , , , , , on March 11, 2009 | Leave a Comment »

The New York Times has an article by Andrew Pollack, “Drug Investors Lose Patience,” about investors pushing biotechnology companies to liquidate and return capital to investors. Pollack notes that such clashes have become much more common in recent months as the stock market crash has pushed the market capitalization of many biotechnology companies to less [...]

Read Full Post »

Greenbackd Portfolio Q1 performance and update

Posted in ARC Wireless Solutions (NASDAQ:ARCW), About, Arrhythmia Research Technology Inc (AMEX:HRT), Audiovox Corporation (NASDAQ:VOXX), Autobytel (NASDAQ:ABTL), Avigen (NASDAQ:AVGN), Axcelis Technologies Inc (NASDAQ:ACLS), Barnwell Industries (AMEX:BRN), Borders Group (NYSE:BGP), Chromcraft Revington (AMEX:CRC), Cobra Electronics Corporation (NASDAQ:COBR), CuraGen Corporation (NASDAQ:CRGN), Ditech Networks Inc (NASDAQ:DITC), Greenbackd, Greenbackd Portfolio, Ikanos Communications Inc (NASDAQ:IKAN), InFocus Corporation (NASDAQ:INFS), Kona Grill Inc (NASDAQ:KONA), MathStar Inc (OTC:MATH), Multimedia Games Inc (NASDAQ:MGAM), Network Engines Inc (NASDAQ:NENG), Neurobiological Technologies Inc (NASDAQ:NTII), Northstar Neuroscience Inc (NASDAQ:NSTR), OrthoLogic Corporation (NASDAQ:CAPS), Soapstone Networks Inc (NASDAQ:SOAP), Stocks, ValueVision Media (NASDAQ:VVTV), Zale Corporation (NYSE:ZLC), tagged , , , , , , , , , , , , , , , , on March 2, 2009 | 10 Comments »

March 1, 2009 marked the end of Greenbackd’s first quarter, so we thought we’d take the opportunity to update you on the performance of the Greenbackd Portfolio and the positions in the portfolio, discuss some changes in our valuation methodology since our first post and outline the future direction of Greenbackd.com. First quarter performance of [...]

Read Full Post »

Neurobiological Technologies Inc (NASDAQ:NTII)

Posted in Activist Investors, Biotechnology Value Fund, Highland Capital Management, Millennium Technology Value Partners, Net Cash Stocks, Neurobiological Technologies Inc (NASDAQ:NTII), Stocks, tagged , , , , , , on February 23, 2009 | 5 Comments »

Neurobiological Technologies Inc (NASDAQ:NTII) is a particularly interesting play. Prima facie, it appears to be a cash-burning biotechnology stock trading at a premium to its liquidating value. In other words, a stock we wouldn’t touch with a ten foot pole. On closer inspection, however, it becomes clear that NTII is trading at its net cash [...]

Read Full Post »